Top Markets
#1 Siren Siren +45.21%
#2 Wrapped NXM Wrapped NXM +12.76%
#3 Cryptopia Cryptopia +9.12%
#4 Mubarak Mubarak +6.70%
#5 Verus Coin Verus Coin +6.66%
#6 Ontology Ontology +6.61%
#7 Helium Helium +6.60%
#8 Axelar Axelar +6.26%
#9 Merlin Chain Merlin Chain +5.91%
#10 Notcoin Notcoin +5.79%
Coin of the day
Siren Siren
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP
Clasificación en acciones #11956
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Precio por acción
$10.30
Última sincronización: 2026-08-11
Capitalización bursátil
$638.32M
Cambio (1 día)
2.88%
Cambio (1 año)
-
País
CA
Comercio Cybin Inc. Common Stock (HELP)

Categoría

Healthcare
Ratio P/S de Cybin Inc. Common Stock (HELP)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Cybin Inc. Common Stock, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Cybin Inc. Common Stock desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH